Table of Contents

Articles

• You have access

  Membrane Potential-Dependent Inhibition of the Na⁺,K⁺-ATPase by para-Nitrobenzyltriethylammonium Bromide

  R. Daniel Peluffo and Joshua R. Berlin

  Molecular Pharmacology July 2012, 82 (1) 1-8; DOI: https://doi.org/10.1124/mol.111.077008
• You have access

  Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification

  Craig H. Kuder, Ryan M. Sheehy, Jeffrey D. Neighbors, David F. Wiemer and Raymond J. Hohl

  Molecular Pharmacology July 2012, 82 (1) 9-16; DOI: https://doi.org/10.1124/mol.111.077107
• You have access

  Influence of the Accessory Protein SET on M3 Muscarinic Receptor Phosphorylation and G Protein Coupling

  Violaine Simon, Sukru S. Oner, Joelle Cohen-Tannoudji, Andrew B. Tobin and Stephen M. Lanier

  Molecular Pharmacology July 2012, 82 (1) 17-26; DOI: https://doi.org/10.1124/mol.111.075523
• You have access

  Fyn Inhibition by Cycloalkane-Fused 1,2-Dithiole-3-thiones Enhances Antioxidant Capacity and Protects Mitochondria from Oxidative Injury

  Ja Hyun Koo, Woo Hyung Lee, Chan Gyu Lee and Sang Geon Kim

  Molecular Pharmacology July 2012, 82 (1) 27-36; DOI: https://doi.org/10.1124/mol.111.077149
• You have access

  The SLCO1A2 Gene, Encoding Human Organic Anion-Transporting Polypeptide 1A2, Is Transactivated by the Vitamin D Receptor

  Jyrki J. Eloranta, Christian Hiller, Moritz Jüttner and Gerd A. Kullak-Ublick

  Molecular Pharmacology July 2012, 82 (1) 37-46; DOI: https://doi.org/10.1124/mol.112.077909
• You have access

  Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo

  Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu

  Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299
• You have access

  Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia

  Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada

  Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992
• You have access

  Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists

  Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger

  Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679
• You have access

  Effects of Nucleotide Analogs at the P2X3 Receptor and Its Mutants Identify the Agonist Binding Pouch

  Thomas Riedel, Sara Wiese, Anna Leichsenring and Peter Illes

  Molecular Pharmacology July 2012, 82 (1) 80-89; DOI: https://doi.org/10.1124/mol.112.077818
• You have access

  Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of K_V Channels

  Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat

  Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188
• You have access

  Architecture and Pore Block of Eukaryotic Voltage-Gated Sodium Channels in View of NavAb Bacterial Sodium Channel Structure

  Denis B. Tikhonov and Boris S. Zhorov

  Molecular Pharmacology July 2012, 82 (1) 97-104; DOI: https://doi.org/10.1124/mol.112.078212
• You have access

  Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect

  Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson

  Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964
• You have access

  Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation

  Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai

  Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354
• You have access

  Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase

  Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson

  Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758
• You have access

  The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II

  Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier

  Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537